CPC A61N 1/36085 (2013.01) [A61B 5/4064 (2013.01); A61N 1/05 (2013.01); A61N 1/0529 (2013.01); A61N 1/36089 (2013.01); A61N 1/36139 (2013.01)] | 9 Claims |
1. A method of detecting an anticipatory biomarker in the form of a low frequency modulation in a nucleus accumbens of a subject in need thereof, wherein the subject in need is one diagnosed with, or suspected of having, a loss of control or impulse control disorder and wherein the subject in need has at least one electrode inserted into their nucleus accumbens, the method comprising:
recording brain wave activity in a frequency range of from 0-38 hertz in the nucleus accumbens of the subject and in the absence of electrical stimulation administered to the brain; and
detecting a change in power compared to a baseline in a delta band corresponding to a frequency of from 1-4 Hz,
wherein detection of an increase in power in the delta band indicates detection of the anticipatory biomarker in the form of a low frequency modulation, wherein said low frequency modulation precedes the onset of a disorder symptom manifestation, wherein the method further comprises preventing the onset by administering, in response to detecting the anticipatory biomarker, an electrical stimulation to the nucleus accumbens of the subject.
|